Developer docs
API playgroundTry for free, no card

Search company profiles

Synaptive Medical

Full company profile

uuid0000q4s

Namestring
Synaptive Medical
Legal namestring
Synaptive Medical Inc.
Company typeenum
Private
Founded yearint
2012
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurosurgical imaging systems, surgical navigation software, robotic surgical visualization, point-of-care MRI, tractography surgical planning
Industry4 codes
1Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
3Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
CodeHLAHADAGPrimaryNo
4Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity)
CodeHLAHADAEPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neurosurgical Imaging and Navigation Systems
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Capital Equipment Sales
TypeHardware Sales
Description

Sale of MRI systems, robotic exoscopes, navigation systems, and surgical planning software as capital equipment to hospitals and health systems.

synaptivemedical.com
2Software Licensing and Support
TypeSubscription Recurring
Description

Software licenses for Modus Plan with annual support and updates included during warranty period. One-year warranty on products with optional technical services support.

synaptivemedical.com
3Professional Services
TypeProfessional Services
Description

Installation, training, and clinical application specialist support. Onsite clinical support available as add-on service.

4Government Contracts
TypeOne Time License
Description

ECAT contract through Fidelis for DoD and VA healthcare facilities for Modus V, valued at $45M over five years.

synaptivemedical.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Modus Plan - Standalone Purchase
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Purchase Modus Plan as standalone product or as part of Synaptive product bundle.

synaptivemedical.com
2Modus Plan - Rent-to-Own
ModelHybridBilling cadenceMonthly
Notes

Flexible option to build toward ownership with monthly payments.

synaptivemedical.com
3Modus Plan - On-Demand
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Quick, on-demand access to patient-specific tractography when needed, includes building toward ownership.

synaptivemedical.com
4Modus Plan Feature Upgrade (Reveal)
ModelSubscriptionBilling cadenceAnnual
Notes

Fractional upgrade charge added to existing Modus Plan software priced at approximately $150,000 base.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Evry
Description

Next-generation, low-field 0.5T MRI with best-in-class head imaging

synaptivemedical.com
+8 more records
Core offering1 text field

Synaptive Medical manufactures and sells an integrated neurosurgical platform combining a 0.5T superconducting head MRI (EVRY), automated tractography surgical planning software (Modus Plan), a robotic exoscope with 4K 3D optics (Modus X/Modus V), and a neuronavigation system (Modus Nav), unified through the ImageDrive Clinical data hub. The suite is sold as capital equipment, software licenses, and supporting services to neurosurgery departments at hospitals, academic medical centers, and government healthcare facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Significant reduction in operative time with Modus X vs operative microscope (n=246)
+6 more records
Product overview1 text field

Synaptive Medical offers an integrated suite of four core neurosurgical products plus supporting modules: EVRY MRI (0.5T superconducting head scanner for point-of-care imaging), Modus Plan (automated tractography surgical planning software), Modus X (robotic exoscope with 4K 3D visualization and fluorescence), and Modus Nav (neuronavigation system). The suite is unified through ImageDrive Clinical, which automates data transfer between products. Supporting modules include Reveal (free water correction), Modus IR (near-infrared fluorescence), and BrightMatter Guide (navigation integration). Modus V (robotic digital microscope) serves as the predecessor platform to Modus X. The integrated architecture enables seamless workflows from diagnosis through treatment management.

Product and service6 records
1EVRY MRI
CategoryMedical Imaging Equipment
Description

Next-generation, low-field 0.5T superconducting head MRI designed for point-of-care imaging. It features a 70% smaller footprint than traditional MRIs, no helium cooling requirement, 8x-40x lower installation costs, 10x better geometric accuracy than legacy MRI, and qualifies for the same high-field MRI reimbursement codes. Sold to hospitals, academic medical centers, and government healthcare facilities.

2Modus Plan
CategorySurgical Planning Software
Description

Surgical planning software that automatically segments whole-brain tractography into patient-specific fiber bundles (corticospinal tract, arcuate fasciculus, etc.) within seconds, enabling neurosurgeons to visualize eloquent neural pathways preoperatively. Sold to neurosurgery departments and used as part of the integrated suite or standalone.

3Modus X
CategoryRobotic Surgical Visualization
Description

Fourth-generation robotic exoscope featuring advanced 4K 3D optics with 27x magnification, automated image focus, voice guidance, and fluorescence visualization capabilities. Used by neurosurgeons, spine, ENT, and reconstructive microsurgeons in hospitals and academic medical centers. Field-upgradeable from the Modus V platform.

4Modus Nav
CategoryNeuronavigation System
Description

Enhanced neuronavigation system with best-in-class tractography for safer, more effective neurosurgical procedures. Provides accurate tracking of multiple intraoperative instruments including suction tools and MIS ports, with integrated free water correction. Integrates with Modus Plan and Modus X for seamless surgical workflow. Sold to neurosurgery departments.

5Modus V
CategoryRobotic Surgical Visualization
Description

Fully automated robotic digital microscope providing hands-free 3D visualization for cranial and spinal procedures. Features a robotically controlled arm, high-definition camera, voice-activated control, AutoFocus, and hands-free camera positioning using tracked instruments. Currently installed in 80+ hospitals worldwide. Field-upgradeable to Modus X.

6ImageDrive Clinical
CategoryClinical Data Integration Platform
Description

Clinical informatics hub that automates data transfer between Synaptive products (EVRY MRI, Modus Plan, Modus X, Modus Nav). Provides real-time quality control for tractography data, seamless plan synchronization, and chronological multi-modal data storage including DICOM, pre/post-op tractography, video, and navigation captures for longitudinal review.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierKeyTypeOthersAnnounced on2026-02-10
Description

Clinical Advisory Board comprised of leading neurosurgeons from UPMC, Mass General Brigham, Stanford, University at Buffalo, Banner Health, USC, St. Michael's Hospital, Indiana University. Provides real-world operating-room and clinical practice insight to inform platform evolution.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2025-10-14
Description

Strategic partnership to integrate Centile Bio's AI-powered brain analytics into Synaptive's Modus Plan software. Combines automated whole-brain tractography with quantitative brain modeling to enhance surgical planning. Currently under development for research and evaluation purposes, with future clinical use subject to regulatory clearances.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

Early Adopter Health Network pilot program to test Synaptive's MRI drape solution designed to prevent COVID-19 contamination on MRI machines, in partnership with UHN.

Strategic tierKeyTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-01-12
Description

Veteran-owned company partnered with Synaptive for ECAT contract awarded by Defense Logistics Agency valued at $45M over 5 years. Enables simplified procurement of Modus V for U.S. Government customers including DoD and VA healthcare facilities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-04-27
Description

Partnership for manufacturing O-Two's e700 portable transport ventilator for COVID-19 patients during pandemic. Synaptive leveraged manufacturing expertise to scale production, part of Ontario consortium to manufacture 10,000 ventilators.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-marketing partnership for BrightMatter Plan announced at CNS (Congress of Neurological Surgeons) for combined product promotion.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Hospital partner conducting first inpatient scans with Evry MRI for stroke detection research. First installation of dedicated head MRI for emergency department assessment.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Manufacturing partner through consortium for ventilator production during COVID-19 pandemic response.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Brainlab is a Munich-based medical technology company specializing in software-driven surgical navigation, planning, and augmented reality for neurosurgery, spine, and other specialties. It is the most direct competitor to Synaptive's Modus Plan and Modus Nav, with overlapping neurosurgical planning and navigation offerings.

TypeBroad incumbent
Description

Carl Zeiss Meditec is a global leader in surgical microscopy (Kinevo 900, OPMI Pentero) and ophthalmic devices, directly competing with Synaptive's Modus X robotic exoscope in neurosurgical visualization. As a multi-billion-dollar incumbent with broad surgical and ophthalmic portfolios, it represents the dominant legacy competitor in the OR visualization market.

TypeBroad incumbent
Description

Medtronic operates the StealthStation neuronavigation system and Mazor spinal robotics platform, providing direct competition to Modus Nav and broader neurosurgery/spine capital equipment. Its scale, hospital relationships, and capital make it the most consequential broad incumbent competitor in surgical navigation and robotics.

TypeBroad incumbent
Description

Stryker's Advanced Guidance Technologies division (formerly acquired MAKO Surgical) competes in surgical navigation and robotics across spine and neurosurgery. Synaptive has an active co-marketing partnership with Stryker's Advanced Guidance Technologies for BrightMatter Plan, indicating overlap and alliance in the neurosurgical navigation space.

TypeDirect peer
Description

Leica Microsystems, now part of Danaher's Beckman Coulter life sciences platform, manufactures neurosurgical microscopes (e.g., M530 OHX, ARveo 8) that directly compete with Synaptive's Modus X and Modus V robotic exoscopes. Both companies target the same neurosurgical visualization use case.

TypeEmerging player
Description

Renishaw's neuromate stereotactic robot is used for neurosurgical procedures including biopsy and DBS, representing an emerging player in the neurosurgical robotics space. Its narrower product portfolio (focused robotics vs Synaptive's integrated suite) positions it as a partial overlap competitor.

TypeEmerging player
Description

7D Surgical (now part of SeaSpine, having spun off its imaging business) developed machine-vision-based surgical navigation for spine procedures. As an emerging navigation player, it competes in the same surgical navigation category as Synaptive's Modus Nav, though with a narrower specialty focus.

TypeEmerging player
Description

Surgical Theater provides VR-based surgical planning and visualization for complex neurosurgical procedures, competing in the surgical planning category alongside Modus Plan. Its focus on 360° VR rendering of patient anatomy provides an alternative approach to tractography-driven planning.

TypeBroad incumbent
Description

Siemens Healthineers is a global MRI incumbent (MAGNETOM family) that competes directly with Synaptive's EVRY MRI in head imaging. Its scale, installed base, and R&D resources make it the most significant competitive threat to EVRY's point-of-care MRI positioning.

TypeBroad incumbent
Description

GE Healthcare is a global MRI incumbent (SIGNA family) and a former employer of multiple Synaptive executives (COO Shawn Campbell, VP Quality Michael McDonald). It competes directly with EVRY in head imaging and has the capital and channel depth to respond to disruptive low-field offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synaptive Medical

Neurosurgical Imaging and Navigation Systemssynaptivemedical.com

Synaptive Medical firmographics

Firmographics
Name
Synaptive Medical
Legal name
Synaptive Medical Inc.
Website
https://synaptivemedical.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Synaptive Medical industry classification

Industry
Product category
Neurosurgical Imaging and Navigation Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE)

Keywords

  • Neurosurgical imaging systems
  • Surgical navigation software
  • Robotic surgical visualization
  • Point-of-care MRI
  • Tractography surgical planning

Where Synaptive Medical is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Synaptive Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Capital Equipment Sales: Sale of MRI systems, robotic exoscopes, navigation systems, and surgical planning software as capital equipment to hospitals and health systems.
  2. Software Licensing and Support: Software licenses for Modus Plan with annual support and updates included during warranty period. One-year warranty on products with optional technical services support.
  3. Professional Services: Installation, training, and clinical application specialist support. Onsite clinical support available as add-on service.
  4. Government Contracts: ECAT contract through Fidelis for DoD and VA healthcare facilities for Modus V, valued at $45M over five years.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractModus Plan - Standalone Purchase
HybridMonthlyModus Plan - Rent-to-Own
Usage-basedPay-as-you-goModus Plan - On-Demand
SubscriptionAnnualModus Plan Feature Upgrade (Reveal)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Synaptive Medical product offering

Product offering

Core offering

Synaptive Medical manufactures and sells an integrated neurosurgical platform combining a 0.5T superconducting head MRI (EVRY), automated tractography surgical planning software (Modus Plan), a robotic exoscope with 4K 3D optics (Modus X/Modus V), and a neuronavigation system (Modus Nav), unified through the ImageDrive Clinical data hub. The suite is sold as capital equipment, software licenses, and supporting services to neurosurgery departments at hospitals, academic medical centers, and government healthcare facilities.

Product overview

Synaptive Medical offers an integrated suite of four core neurosurgical products plus supporting modules: EVRY MRI (0.5T superconducting head scanner for point-of-care imaging), Modus Plan (automated tractography surgical planning software), Modus X (robotic exoscope with 4K 3D visualization and fluorescence), and Modus Nav (neuronavigation system). The suite is unified through ImageDrive Clinical, which automates data transfer between products. Supporting modules include Reveal (free water correction), Modus IR (near-infrared fluorescence), and BrightMatter Guide (navigation integration). Modus V (robotic digital microscope) serves as the predecessor platform to Modus X. The integrated architecture enables seamless workflows from diagnosis through treatment management.

Differentiator

Problem solved

Functional benefit

Brands

  • Evry: Next-generation, low-field 0.5T MRI with best-in-class head imaging
  • Modus Plan
  • Modus X
  • Modus Nav
  • Modus V
  • BrightMatter
  • ImageDrive Clinical
  • Modus IR
  • Reveal

Products and services

  • EVRY MRI Next-generation, low-field 0.5T superconducting head MRI designed for point-of-care imaging. It features a 70% smaller footprint than traditional MRIs, no helium cooling requirement, 8x-40x lower installation costs, 10x better geometric accuracy than legacy MRI, and qualifies for the same high-field MRI reimbursement codes. Sold to hospitals, academic medical centers, and government healthcare facilities.
  • Modus Plan Surgical planning software that automatically segments whole-brain tractography into patient-specific fiber bundles (corticospinal tract, arcuate fasciculus, etc.) within seconds, enabling neurosurgeons to visualize eloquent neural pathways preoperatively. Sold to neurosurgery departments and used as part of the integrated suite or standalone.
  • Modus X Fourth-generation robotic exoscope featuring advanced 4K 3D optics with 27x magnification, automated image focus, voice guidance, and fluorescence visualization capabilities. Used by neurosurgeons, spine, ENT, and reconstructive microsurgeons in hospitals and academic medical centers. Field-upgradeable from the Modus V platform.
  • Modus Nav Enhanced neuronavigation system with best-in-class tractography for safer, more effective neurosurgical procedures. Provides accurate tracking of multiple intraoperative instruments including suction tools and MIS ports, with integrated free water correction. Integrates with Modus Plan and Modus X for seamless surgical workflow. Sold to neurosurgery departments.
  • Modus V Fully automated robotic digital microscope providing hands-free 3D visualization for cranial and spinal procedures. Features a robotically controlled arm, high-definition camera, voice-activated control, AutoFocus, and hands-free camera positioning using tracked instruments. Currently installed in 80+ hospitals worldwide. Field-upgradeable to Modus X.
  • ImageDrive Clinical Clinical informatics hub that automates data transfer between Synaptive products (EVRY MRI, Modus Plan, Modus X, Modus Nav). Provides real-time quality control for tractography data, seamless plan synchronization, and chronological multi-modal data storage including DICOM, pre/post-op tractography, video, and navigation captures for longitudinal review.

Quantifiable outcome

  • Significant reduction in operative time with Modus X vs operative microscope (n=246)
  • +6 more outcomes

Companies that use Synaptive Medical

Customer profile

Named customers16 records

Segments5 records

Ideal customer profiles3 records

Synaptive Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Synaptive Medical partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered key, strategic and minor.

  • Clinical Advisory Board MemberskeyOthers · 10 February 2026Clinical Advisory Board comprised of leading neurosurgeons from UPMC, Mass General Brigham, Stanford, University at Buffalo, Banner Health, USC, St. Michael's Hospital, Indiana University. Provides real-world operating-room and clinical practice insight to inform platform evolution.
  • Centile BiosciencestrategicTechnology or Integration · 14 October 2025Strategic partnership to integrate Centile Bio's AI-powered brain analytics into Synaptive's Modus Plan software. Combines automated whole-brain tractography with quantitative brain modeling to enhance surgical planning. Currently under development for research and evaluation purposes, with future clinical use subject to regulatory clearances.
  • Ontario Bioscience Innovation Organization (OBIO)minorStrategic or Co-development Partner · 1 June 2021Early Adopter Health Network pilot program to test Synaptive's MRI drape solution designed to prevent COVID-19 contamination on MRI machines, in partnership with UHN.
  • Fidelis Sustainability DistributionkeyChannel Partner/ Reseller/ Distributor · 12 January 2021Veteran-owned company partnered with Synaptive for ECAT contract awarded by Defense Logistics Agency valued at $45M over 5 years. Enables simplified procurement of Modus V for U.S. Government customers including DoD and VA healthcare facilities.
  • O-Two Medical TechnologiesminorStrategic or Co-development Partner · 27 April 2020Partnership for manufacturing O-Two's e700 portable transport ventilator for COVID-19 patients during pandemic. Synaptive leveraged manufacturing expertise to scale production, part of Ontario consortium to manufacture 10,000 ventilators.
  • Stryker's Advanced Guidance TechnologiesminorGTM or Marketing PartnerCo-marketing partnership for BrightMatter Plan announced at CNS (Congress of Neurological Surgeons) for combined product promotion.
  • Nova Scotia Health (Queen Elizabeth II Health Sciences Centre)keyStrategic or Co-development PartnerHospital partner conducting first inpatient scans with Evry MRI for stroke detection research. First installation of dedicated head MRI for emergency department assessment.
  • LinamarminorStrategic or Co-development PartnerManufacturing partner through consortium for ventilator production during COVID-19 pandemic response.

Scale indicators9 records

Recent moves6 records

Synaptive Medical competitors and assessment

Company assessment

Direct peers

  • Brainlab: Brainlab is a Munich-based medical technology company specializing in software-driven surgical navigation, planning, and augmented reality for neurosurgery, spine, and other specialties. It is the most direct competitor to Synaptive's Modus Plan and Modus Nav, with overlapping neurosurgical planning and navigation offerings.
  • Leica Microsystems (Danaher): Leica Microsystems, now part of Danaher's Beckman Coulter life sciences platform, manufactures neurosurgical microscopes (e.g., M530 OHX, ARveo 8) that directly compete with Synaptive's Modus X and Modus V robotic exoscopes. Both companies target the same neurosurgical visualization use case.

Broad incumbents

  • Carl Zeiss Meditec: Carl Zeiss Meditec is a global leader in surgical microscopy (Kinevo 900, OPMI Pentero) and ophthalmic devices, directly competing with Synaptive's Modus X robotic exoscope in neurosurgical visualization. As a multi-billion-dollar incumbent with broad surgical and ophthalmic portfolios, it represents the dominant legacy competitor in the OR visualization market.
  • Medtronic: Medtronic operates the StealthStation neuronavigation system and Mazor spinal robotics platform, providing direct competition to Modus Nav and broader neurosurgery/spine capital equipment. Its scale, hospital relationships, and capital make it the most consequential broad incumbent competitor in surgical navigation and robotics.
  • Stryker: Stryker's Advanced Guidance Technologies division (formerly acquired MAKO Surgical) competes in surgical navigation and robotics across spine and neurosurgery. Synaptive has an active co-marketing partnership with Stryker's Advanced Guidance Technologies for BrightMatter Plan, indicating overlap and alliance in the neurosurgical navigation space.
  • Siemens Healthineers: Siemens Healthineers is a global MRI incumbent (MAGNETOM family) that competes directly with Synaptive's EVRY MRI in head imaging. Its scale, installed base, and R&D resources make it the most significant competitive threat to EVRY's point-of-care MRI positioning.
  • GE Healthcare: GE Healthcare is a global MRI incumbent (SIGNA family) and a former employer of multiple Synaptive executives (COO Shawn Campbell, VP Quality Michael McDonald). It competes directly with EVRY in head imaging and has the capital and channel depth to respond to disruptive low-field offerings.

Emerging players

  • Renishaw: Renishaw's neuromate stereotactic robot is used for neurosurgical procedures including biopsy and DBS, representing an emerging player in the neurosurgical robotics space. Its narrower product portfolio (focused robotics vs Synaptive's integrated suite) positions it as a partial overlap competitor.
  • 7D Surgical: 7D Surgical (now part of SeaSpine, having spun off its imaging business) developed machine-vision-based surgical navigation for spine procedures. As an emerging navigation player, it competes in the same surgical navigation category as Synaptive's Modus Nav, though with a narrower specialty focus.
  • Surgical Theater: Surgical Theater provides VR-based surgical planning and visualization for complex neurosurgical procedures, competing in the surgical planning category alongside Modus Plan. Its focus on 360° VR rendering of patient anatomy provides an alternative approach to tractography-driven planning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Synaptive Medical social profiles

Digital presence

Synaptive Medical compliance and trust

Trust signal

Compliance3 records

Synaptive Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synaptive Medical leadership team

Management profile

Number of profiles

Profiles11 records

Synaptive Medical funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synaptive Medical M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synaptive Medical

What does Synaptive Medical do?

Synaptive Medical manufactures and sells an integrated neurosurgical platform combining a 0.5T superconducting head MRI (EVRY), automated tractography surgical planning software (Modus Plan), a robotic exoscope with 4K 3D optics (Modus X/Modus V), and a neuronavigation system (Modus Nav), unified through the ImageDrive Clinical data hub. The suite is sold as capital equipment, software licenses, and supporting services to neurosurgery departments at hospitals, academic medical centers, and government healthcare facilities.

Is Synaptive Medical a public or private company?

Synaptive Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Synaptive Medical founded?

Synaptive Medical was founded in 2012. It employs 51 to 100 people.

Where is Synaptive Medical based?

Synaptive Medical is headquartered in Toronto, Canada, in the North America region.

How does Synaptive Medical make money?

Four revenue lines are on record. Capital Equipment Sales are the primary driver. The others are software Licensing and Support, professional Services and government Contracts.

Who are Synaptive Medical's main competitors?

Direct peers on record are Brainlab and Leica Microsystems (Danaher). Broad incumbents are Carl Zeiss Meditec, Medtronic, Stryker, Siemens Healthineers and GE Healthcare. Emerging players are Renishaw, 7D Surgical and Surgical Theater.

Does Synaptive Medical have an API?

No public API is recorded for Synaptive Medical.

What industry is Synaptive Medical in?

Synaptive Medical's product category is Neurosurgical Imaging and Navigation Systems. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireSALES PROCESS OF SYNAPTIVE MEDICAL INC.Richter Inc., as receiver of Synaptive Medical Inc., initiated a sale and investment solicitation process for the company's assets under an Ontario court order. Interested parties must sign a non-disclosure agreement, with a qualifying offer deadline of June 5, 2026, and an outside closing date of June 30, 2026.Financial PostSynaptive Medical Announces Formation of Clinical Advisory Board Comprised of Global Surgical and Imaging LeadersSynaptive Medical announced the formation of a Clinical Advisory Board bringing together a group of leading clinician-scientists to guide the company's long-term clinical and technology strategy across its surgical visualization, navigation, and MRI platforms used in neurosurgery. The initial board members include five distinguished surgeons and physician-scientists from institutions including the University of Pittsburgh Medical Center, Mass General Brigham, and Stanford University. The board is intended to ensure the company's innovation remains aligned with real-world clinical practice and to support evidence generation as Synaptive scales across neurosurgery and adjacent clinical domains worldwide.Business Wire BlogSynaptive Medical Announces Formation of Clinical Advisory Board Comprised of Global Surgical and Imaging LeadersSynaptive Medical announced the formation of a Clinical Advisory Board comprising leading clinicians and surgeon-scientists to guide the company's long-term clinical and technology strategy across its surgical visualization, navigation, and MRI platforms. The board, which held its inaugural meeting, will serve as a forum providing operating-room and clinical practice insight to inform platform evolution, clinical priorities, and evidence generation as the company scales across neurosurgery and adjacent clinical domains worldwide. This initiative reflects Synaptive's commitment to integrating clinical reality with technological innovation, ensuring responsible deployment across diverse healthcare settings.GlobeNewswireSynaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual MeetingSynaptive Medical is showcasing the first clinical use of its new near-infrared fluorescence visualization, Modus IR, on the Modus X robotic exoscope at the American Association of Neurological Surgeons annual meeting. Since receiving FDA clearance in March, the technology has been utilized by surgeons for complex cerebrovascular procedures such as aneurysm clippings and cerebral bypasses, as well as in plastic and ENT surgeries. Feedback indicates that the system allows optics to be placed further from anatomy than traditional methods, streamlining workflow while providing improved tissue contrast.GlobeNewswireSynaptive Medical Welcomes Chris Marrus as New Chief Commercial OfficerSynaptive Medical appointed Chris Marrus as Chief Commercial Officer on Feb. 29, 2024, to drive sales and growth. Marrus previously led commercialization at INSIGHTEC, Stryker, MAKO Surgical, Intuitive Surgical, and Leica. He will oversee global sales across 16 countries and marketing, product management, and clinical applications.GlobeNewswireSynaptive Medical Announces Timothy J. Scannell as New Chair of Board of DirectorsSynaptive Medical appointed Timothy J. Scannell as chair of its board of directors, effective June 20, 2023. Scannell previously served as president and COO of Stryker from 2018 to 2021. He will help guide the company's growth in surgical visualization, navigation, robotics, and MRI.GlobeNewswireSynaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D ActivitiesSynaptive Medical received $900,000 from the Ontario government to expand manufacturing and R&D for its head-only MRI system. The funding supports a $2.8 million project, with the MRI designed for point-of-care diagnostics in urgent cases like brain tumours and stroke.GlobeNewswireSynaptive Medical Inc. Awarded Inaugural INOVAIT Focus Fund Investments to Fund MRI ProjectSynaptive Medical Inc. received an INOVAIT Focus Fund investment to support MRI research and development for image-guided therapies. The funding will advance its 0.5 T MRI system and clinical evaluation of AI-accelerated imaging with Dalhousie University. The company was one of 14 projects selected in the inaugural call.GlobeNewswireSynaptive Medical Inc., Launches Dynamic Free Water Correction Feature to Enhance Planning and Navigation TechnologySynaptive Medical launched Reveal, a free water correction feature for its Modus Plan software, to recover eloquent tracts near brain lesions affected by edema. The feature aims to improve tractography visibility and surgical planning, with integration into hospital systems pending regulatory clearance. Synaptive will showcase the update at the Congress of Neurological Surgeons in October.GlobeNewswireSynaptive Medical Appoints Mark Hanrahan as Chief Financial OfficerSynaptive Medical appointed Mark Hanrahan as Chief Financial Officer, bringing over 14 years of financial leadership. He previously served as Chief Strategy Officer at Just Energy and VP at Barrick Gold. The company closed an $80 million Series B round in December 2020 to support growth.